| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8285923 | Parkinsonism & Related Disorders | 2016 | 8 Pages |
Abstract
Baseline cognitive status and mood influence the rate of disease progression in PSP. Multiple clinical, neuropsychological, and volumetric MRI measurements are sensitive to change over one year in PSP and appropriate for use in multicenter clinical trials.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Jee Bang, Iryna V. Lobach, Anthony E. Lang, Murray Grossman, David S. Knopman, Bruce L. Miller, Lon S. Schneider, Rachelle S. Doody, Andrew Lees, Michael Gold, Bruce H. Morimoto, Adam L. Boxer, AL-108-231 Investigators AL-108-231 Investigators,